https://www.selleckchem.com/pr....oducts/gusacitinib.h
Two studies evaluated eHealth as part of the medical management and showed a reduction in hospitalisation rate. The evidence of eHealth supporting the management of people with PAH is limited and only embraced through a few studies of small sample size and short-term duration. Given the proposed clinical benefits in heart failure, we postulate that the evaluation of eHealth for the clinical management of PAH is highly warranted. The evidence of eHealth supporting the management of people with PAH is limited and only embraced through
Like
Comment
Share
